These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23934523)

  • 1. [Development of drugs to treat autoimmune disease - from biologics to small molecules].
    Muramoto K
    Nihon Yakurigaku Zasshi; 2013 Aug; 142(2):58-62. PubMed ID: 23934523
    [No Abstract]   [Full Text] [Related]  

  • 2. Thematic issue: Biologics in autoimmune diseases.
    Sciascia S; Cuadrado MJ
    Int Immunopharmacol; 2015 Aug; 27(2):179. PubMed ID: 25962817
    [No Abstract]   [Full Text] [Related]  

  • 3. Biologics in autoimmune diseases.
    Shi G; Liu Y
    Curr Pharm Biotechnol; 2014; 15(6):509. PubMed ID: 25213358
    [No Abstract]   [Full Text] [Related]  

  • 4. Biologics for the treatment of autoimmune renal diseases.
    Holdsworth SR; Gan PY; Kitching AR
    Nat Rev Nephrol; 2016 Apr; 12(4):217-31. PubMed ID: 26949177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologics in Inflammatory Immune-mediated Systemic Diseases.
    Moroncini G; Calogera G; Benfaremo D; Gabrielli A
    Curr Pharm Biotechnol; 2017; 18(12):1008-1016. PubMed ID: 29278213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Igniting Small-Molecule Drug Discovery.
    Steinhagen H
    ChemMedChem; 2016 Jan; 11(2):148-9. PubMed ID: 26781775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune consequences of biologics.
    Dhital R; Kavanaugh A
    J Allergy Clin Immunol; 2022 Jan; 149(1):48-50. PubMed ID: 34838586
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of Biologics and Biosimilars in Rheumatology.
    Sharma SK
    J Assoc Physicians India; 2017 May; 65(5 Suppl):9-14. PubMed ID: 28836745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is it time for biosimilars in autoimmune diseases?
    Cuadrado MJ; Sciascia S; Bosch X; Khamashta MA; Ramos-Casals M
    Autoimmun Rev; 2013 Aug; 12(10):954-7. PubMed ID: 23542505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of preterm delivery and small-for-gestational-age births in women with autoimmune disease using biologics before or during pregnancy: a population-based cohort study.
    Tsao NW; Sayre EC; Hanley G; Sadatsafavi M; Lynd LD; Marra CA; De Vera MA
    Ann Rheum Dis; 2018 Jun; 77(6):869-874. PubMed ID: 29496718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic glucocorticoids confound SARS-CoV-2 acquisition or even clinical outcomes in patients with autoimmune disease treated with biologics: comment on the article by Simon et al.
    Niu MM; Jiang Q; Zhang YF; Li DT; Yang Q; Hu P
    Arthritis Rheumatol; 2022 Dec; 74(12):2042-2043. PubMed ID: 35819807
    [No Abstract]   [Full Text] [Related]  

  • 12. The Corrona US registry of rheumatic and autoimmune diseases.
    Kremer JM
    Clin Exp Rheumatol; 2016; 34(5 Suppl 101):S96-S99. PubMed ID: 27762197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of Biologics Utilization and Discontinuation Before and During Pregnancy in Women With Autoimmune Diseases: A Population-Based Cohort Study.
    Tsao NW; Lynd LD; Sadatsafavi M; Hanley G; De Vera MA
    Arthritis Care Res (Hoboken); 2018 Jul; 70(7):979-986. PubMed ID: 28973840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural products with anti-inflammatory and immunomodulatory activities against autoimmune myocarditis.
    Javadi B; Sahebkar A
    Pharmacol Res; 2017 Oct; 124():34-42. PubMed ID: 28757189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologics and postbiologics: novel immunotherapeutics for the induction and maintenance of remission.
    van Eden W; Lisse J; Prakken B; Albani S
    Drug Discov Today; 2010 Jan; 15(1-2):71-7. PubMed ID: 19162218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune diseases: Inhibitor of adaptor protein shows self-antigen selectivity.
    Flemming A
    Nat Rev Drug Discov; 2017 Feb; 16(2):86. PubMed ID: 28148933
    [No Abstract]   [Full Text] [Related]  

  • 17. Biosimilars for Immune-Mediated Chronic Diseases in Primary Care: What a Practicing Physician Needs to Know.
    Feldman SR; Bagel J; Namak S
    Am J Med Sci; 2018 May; 355(5):411-417. PubMed ID: 29753369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic Therapies for Rheumatologic and Autoimmune Conditions.
    Bays AM; Gardner G
    Med Clin North Am; 2016 Jul; 100(4):719-31. PubMed ID: 27235612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunology Update: Biologics.
    Starr SP
    FP Essent; 2016 Nov; 450():11-21. PubMed ID: 27869438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologics and risk of tuberculosis in autoimmune rheumatic diseases: A real-world clinical experience from India.
    Shobha V; Chandrashekara S; Rao V; Desai A; Jois R; Dharmanand BG; Kumar S; Kumar P; Dharmapalaiah C; Mahendranath KM; Prasad S; Daware MA; Singh Y; Karjigi U; Nagaraj S; Anupama KR
    Int J Rheum Dis; 2019 Feb; 22(2):280-287. PubMed ID: 30168281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.